Orion Biotech Opportunities Stock Price, News & Analysis
Company Description
Orion Biotech Opportunities (OTC: ORIAU) is a publicly traded shell companies company in the Financial Services sector.
ORIAU stock has declined 8.3% over the past year.
This page provides a comprehensive overview of ORIAU stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Orion Biotech Opportunities (ORIAU) stock. Over the past 12 months, the stock has lost 8.3%.
Latest News
Orion Biotech Opportunities has 3 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include IPO, offering. View all ORIAU news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ORIAU Company Profile & Sector Positioning
Orion Biotech Opportunities (ORIAU) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the OTC.
Investors comparing ORIAU often look at related companies in the same sector, including ARMADA ACQUISITION CORP III (AACIU), ARMADA ACQUISITION CORP III (AACIW), Ace Convergence Acqu Corp (ACEVU), Independence Holdings Corp (ACQRU), and Arclight Clean Transition Corp Ii (ACTDU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ORIAU's relative position within its industry.